These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 33728589)

  • 1. AYA Considerations for Aggressive Lymphomas.
    Llaurador G; Giulino-Roth L
    Curr Hematol Malig Rep; 2021 Feb; 16(1):61-71. PubMed ID: 33728589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Therapies in Relapsed and Refractory Hodgkin Lymphoma: What Comes Next After Brentuximab Vedotin and PD-1 Inhibition?
    Othman T; Herrera A; Mei M
    Curr Hematol Malig Rep; 2021 Feb; 16(1):1-7. PubMed ID: 33409966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study.
    Zawati I; Adouni O; Finetti P; Manai M; Manai M; Gamoudi A; Birnbaum D; Bertucci F; Mezlini A
    Cancer Radiother; 2020 Jun; 24(3):206-214. PubMed ID: 32171674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ipilimumab, nivolumab, and brentuximab vedotin combination therapies in patients with relapsed or refractory Hodgkin lymphoma: phase 1 results of an open-label, multicentre, phase 1/2 trial.
    Diefenbach CS; Hong F; Ambinder RF; Cohen JB; Robertson MJ; David KA; Advani RH; Fenske TS; Barta SK; Palmisiano ND; Svoboda J; Morgan DS; Karmali R; Sharon E; Streicher H; Kahl BS; Ansell SM
    Lancet Haematol; 2020 Sep; 7(9):e660-e670. PubMed ID: 32853585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brentuximab vedotin plus nivolumab as first-line therapy in older or chemotherapy-ineligible patients with Hodgkin lymphoma (ACCRU): a multicentre, single-arm, phase 2 trial.
    Cheson BD; Bartlett NL; LaPlant B; Lee HJ; Advani RJ; Christian B; Diefenbach CS; Feldman TA; Ansell SM
    Lancet Haematol; 2020 Nov; 7(11):e808-e815. PubMed ID: 33010817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A targeted salvage therapy with Brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients before and after stem cell transplantation.
    Taçyıldız N; Tanyıldız HG; Ünal E; Dinçaslan H; Asarcıklı F; Aksoy BA; Vatansever G; Yavuz G
    Turk J Pediatr; 2019; 61(5):671-676. PubMed ID: 32104998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classic Hodgkin Lymphoma in Adolescents and Young Adults.
    Kelly KM; Friedberg JW
    J Clin Oncol; 2024 Feb; 42(6):653-664. PubMed ID: 37983570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adolescent and young adult Hodgkin lymphoma: Raising the bar through collaborative science and multidisciplinary care.
    Kahn JM; Kelly KM
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27033. PubMed ID: 29603618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 study.
    Kuruvilla J; Ramchandren R; Santoro A; Paszkiewicz-Kozik E; Gasiorowski R; Johnson NA; Fogliatto LM; Goncalves I; de Oliveira JSR; Buccheri V; Perini GF; Goldschmidt N; Kriachok I; Dickinson M; Komarnicki M; McDonald A; Ozcan M; Sekiguchi N; Zhu Y; Nahar A; Marinello P; Zinzani PL;
    Lancet Oncol; 2021 Apr; 22(4):512-524. PubMed ID: 33721562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversies in the management of early-stage Hodgkin lymphoma.
    Blum KA
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):234-239. PubMed ID: 34889367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of Hodgkin lymphoma in adolescents and young adults: burden of disease or burden of choice?
    Flerlage JE; Metzger ML; Bhakta N
    Blood; 2018 Jul; 132(4):376-384. PubMed ID: 29895665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoma in Adolescents and Young Adults.
    Brugières L; Brice P
    Prog Tumor Res; 2016; 43():101-14. PubMed ID: 27595360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoma in adolescents and young adults.
    Jaglowski SM; Linden E; Termuhlen AM; Flynn JM
    Semin Oncol; 2009 Oct; 36(5):381-418. PubMed ID: 19835736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute lymphoblastic leukemia in young adults: which treatment?
    McNeer JL; Raetz EA
    Curr Opin Oncol; 2012 Sep; 24(5):487-94. PubMed ID: 22691923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of brentuximab vedotin as a treatment option for stage III/IV Hodgkin lymphoma.
    Choi Y; Diefenbach CS
    Expert Rev Hematol; 2019 Oct; 12(10):801-808. PubMed ID: 31432732
    [No Abstract]   [Full Text] [Related]  

  • 16. Brentuximab Vedotin as Consolidation Therapy After Autologous Stem Cell Transplantation in Children and Adolescents (<18 y) With Early Relapse Hodgkin Lymphoma.
    Fernández KS; Mavers M; Marks LJ; Agarwal R
    J Pediatr Hematol Oncol; 2021 Mar; 43(2):e191-e194. PubMed ID: 31876780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brentuximab vedotin as a salvage treatment for relapsed and refractory Hodgkin lymphoma patients in Taiwan.
    Tien FM; Tsai CH; Liu JH; Lin CT
    J Formos Med Assoc; 2019 Oct; 118(10):1466-1470. PubMed ID: 31337522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Mediastinal B-Cell Lymphoma in Children and Young Adults.
    Forlenza CJ; Chadburn A; Giulino-Roth L
    J Natl Compr Canc Netw; 2023 Mar; 21(3):323-330. PubMed ID: 36898366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidisciplinary Management of Adolescent and Young Adult Patients with Hodgkin Lymphoma.
    Galloway E; Griffith M; Rosenthal A
    Curr Treat Options Oncol; 2021 Jun; 22(7):64. PubMed ID: 34097142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of Hodgkin lymphoma in children, adolescents, and young adults.
    Belsky JA; Hochberg J; Giulino-Roth L
    Best Pract Res Clin Haematol; 2023 Mar; 36(1):101445. PubMed ID: 36907636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.